Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.

Rühl H, Berens C, Winterhagen FI, Reda S, Müller J, Oldenburg J, Pötzsch B.

Circ Res. 2019 Aug 16;125(5):523-534. doi: 10.1161/CIRCRESAHA.119.315037. Epub 2019 Jul 17.

PMID:
31314700
2.

Activity Pattern Analysis Indicates Increased but Balanced Systemic Coagulation Activity in Response to Surgical Trauma.

Friedrich MJ, Schmolders J, Rommelspacher Y, Strauss A, Rühl H, Mayer G, Oldenburg J, Wirtz DC, Müller J, Pötzsch B.

TH Open. 2018 Oct 1;2(4):e350-e356. doi: 10.1055/s-0038-1673390. eCollection 2018 Oct.

3.

Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A.

Müller J, Pekrul I, Pötzsch B, Berning B, Oldenburg J, Spannagl M.

Thromb Haemost. 2019 Sep;119(9):1384-1393. doi: 10.1055/s-0039-1692427. Epub 2019 Jun 16.

4.

Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

Bäuml CA, Schmitz T, Paul George AA, Sudarsanam M, Hardes K, Steinmetzer T, Holle LA, Wolberg AS, Pötzsch B, Oldenburg J, Biswas A, Imhof D.

J Med Chem. 2019 Apr 11;62(7):3513-3523. doi: 10.1021/acs.jmedchem.8b01982. Epub 2019 Mar 21.

PMID:
30852892
5.

The evolution of activated protein C plasma levels in septic shock and its association with mortality: A prospective observational study.

Becher T, Müller J, Akin I, Baumann S, Bosch K, Stach K, Borggrefe M, Pötzsch B, Loßnitzer D.

J Crit Care. 2018 Oct;47:41-48. doi: 10.1016/j.jcrc.2018.06.003. Epub 2018 Jun 2.

PMID:
29886066
6.

In vivo thrombin generation and subsequent APC formation are increased in factor V Leiden carriers.

Rühl H, Winterhagen FI, Berens C, Müller J, Oldenburg J, Pötzsch B.

Blood. 2018 Mar 29;131(13):1489-1492. doi: 10.1182/blood-2017-12-823831. Epub 2018 Feb 21. No abstract available.

PMID:
29467181
7.

Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era.

Rühl H, Reda S, Müller J, Oldenburg J, Pötzsch B.

Thromb Haemost. 2018 Feb;118(2):381-387. doi: 10.1160/TH17-08-0568. Epub 2018 Jan 29.

PMID:
29378360
8.

The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.

Ponert JM, Schwarz S, Haschemi R, Müller J, Pötzsch B, Bendas G, Schlesinger M.

PLoS One. 2018 Jan 18;13(1):e0191303. doi: 10.1371/journal.pone.0191303. eCollection 2018.

9.

Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.

Schindewolf M, Steindl J, Beyer-Westendorf J, Schellong S, Dohmen PM, Brachmann J, Madlener K, Pötzsch B, Klamroth R, Hankowitz J, Banik N, Eberle S, Müller MM, Kropff S, Lindhoff-Last E.

J Am Coll Cardiol. 2017 Nov 28;70(21):2636-2648. doi: 10.1016/j.jacc.2017.09.1099.

10.

Investigation of dominant and recessive inheritance models in genome-wide association studies data of nonsyndromic cleft lip with or without cleft palate.

Böhmer AC, Gölz L, Kreusch T, Kramer FJ, Pötzsch B, Nöthen MM, Jäger A, Mangold E, Knapp M, Ludwig KU.

Birth Defects Res. 2018 Mar 1;110(4):336-341. doi: 10.1002/bdr2.1144. Epub 2017 Nov 14.

PMID:
29134786
11.

Anxiety and depression in patients three months after myocardial infarction: Association with markers of coagulation and the relevance of age.

Geiser F, Urbach AS, Harbrecht U, Conrad R, Pötzsch B, Amann N, Kiesewetter K, Sieke A, Wolffs K, Skowasch D.

J Psychosom Res. 2017 Aug;99:162-168. doi: 10.1016/j.jpsychores.2017.06.015. Epub 2017 Jun 19.

PMID:
28712423
12.

Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.

Sedaghat A, Kulka H, Sinning JM, Falkenberg N, Driesen J, Preisler B, Hammerstingl C, Nickenig G, Pötzsch B, Oldenburg J, Hertfelder HJ, Werner N.

Thromb Res. 2017 Mar;151:23-28. doi: 10.1016/j.thromres.2016.12.027. Epub 2017 Jan 7.

PMID:
28088607
13.

In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach.

Hamedani NS, Rühl H, Zimmermann JJ, Heiseler T, Oldenburg J, Mayer G, Pötzsch B, Müller J.

Nucleic Acid Ther. 2016 Dec;26(6):355-362. Epub 2016 Oct 13.

PMID:
27736370
14.

Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.

Berens C, Heine A, Müller J, Held SA, Mayer K, Brossart P, Oldenburg J, Pötzsch B, Wolf D, Rühl H.

Cytotherapy. 2016 Oct;18(10):1325-31. doi: 10.1016/j.jcyt.2016.06.014. Epub 2016 Aug 1.

PMID:
27491794
15.

TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia.

Sedaghat A, Falkenberg N, Sinning JM, Kulka H, Hammerstingl C, Nickenig G, Oldenburg J, Pötzsch B, Werner N.

Int J Cardiol. 2016 Oct 15;221:719-25. doi: 10.1016/j.ijcard.2016.07.094. Epub 2016 Jul 5.

PMID:
27424316
16.

Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.

Berens C, Rühl H, Ivaškevičius V, Oldenburg J, Hertfelder HJ, Pötzsch B.

Thromb Haemost. 2016 May 2;115(5):1073-5. doi: 10.1160/TH15-10-0818. Epub 2016 Jan 14. No abstract available.

PMID:
26763372
17.

Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.

Rühl H, Berens C, Winterhagen A, Müller J, Oldenburg J, Pötzsch B.

PLoS One. 2015 Dec 14;10(12):e0145012. doi: 10.1371/journal.pone.0145012. eCollection 2015.

18.

Aptamer-Based Enzyme Capture Assay for Measurement of Plasma Thrombin Levels.

Müller J, Becher T, Mayer G, Pötzsch B.

Methods Mol Biol. 2016;1380:179-89. doi: 10.1007/978-1-4939-3197-2_15.

PMID:
26552826
19.

Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.

Ivaškevičius V, Goldmann G, Biswas A, Westhofen P, Thomas A, Marquardt N, Horneff S, Klein C, Rühl H, Pötzsch B, Oldenburg J.

Hamostaseologie. 2015;35 Suppl 1:S32-5.

PMID:
26540128
20.

Management of Portal/Mesenteric Vein Occlusion.

Sauerbuch T, Hopt UT, Neeff H, Pötzsch B, Rössle M, Valla D.

Viszeralmedizin. 2014 Dec;30(6):417-20. doi: 10.1159/000369153. Epub 2014 Dec 3. No abstract available.

21.

Tranexamic Acid for Hyperfibrinolytic Hemorrhage During Conservative Management of Placenta Percreta.

Schröder L, Pötzsch B, Rühl H, Gembruch U, Merz WM.

Obstet Gynecol. 2015 Nov;126(5):1012-5. doi: 10.1097/AOG.0000000000000915.

PMID:
26132457
22.

Capture and Release (CaR): a simplified procedure for one-tube isolation and concentration of single-stranded DNA during SELEX.

Hamedani NS, Blümke F, Tolle F, Rohrbach F, Rühl H, Oldenburg J, Mayer G, Pötzsch B, Müller J.

Chem Commun (Camb). 2015 Jan 21;51(6):1135-8. doi: 10.1039/c4cc08233h.

PMID:
25466441
23.

Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study.

Rühl H, Schröder L, Müller J, Sukhitashvili S, Welz J, Kuhn WC, Oldenburg J, Rudlowski C, Pötzsch B.

PLoS One. 2014 Aug 14;9(8):e105007. doi: 10.1371/journal.pone.0105007. eCollection 2014.

24.

Short-term venous stasis induces fibrinolytic activation but not thrombin formation.

Rühl H, Müller J, Wäschenbach J, Oldenburg J, Dewald O, Pötzsch B.

J Atheroscler Thromb. 2014;21(12):1260-70. Epub 2014 Jul 29.

25.

[Outpatient anticoagulation].

Pötzsch B.

MMW Fortschr Med. 2014 May 15;156(9):48-53; quiz 54-5. Review. German. No abstract available.

PMID:
24908890
26.

Nonsyndromic cleft lip with or without cleft palate: Increased burden of rare variants within Gremlin-1, a component of the bone morphogenetic protein 4 pathway.

Al Chawa T, Ludwig KU, Fier H, Pötzsch B, Reich RH, Schmidt G, Braumann B, Daratsianos N, Böhmer AC, Schuencke H, Alblas M, Fricker N, Hoffmann P, Knapp M, Lange C, Nöthen MM, Mangold E.

Birth Defects Res A Clin Mol Teratol. 2014 Jun;100(6):493-8. doi: 10.1002/bdra.23244. Epub 2014 Apr 7.

PMID:
24706492
27.

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.

Schindewolf M, Steindl J, Beyer-Westendorf J, Schellong S, Dohmen PM, Brachmann J, Madlener K, Pötzsch B, Klamroth R, Hankowitz J, Banik N, Eberle S, Kropff S, Müller MM, Lindhoff-Last E.

Thromb Res. 2014 Jul;134(1):29-35. doi: 10.1016/j.thromres.2014.03.029. Epub 2014 Mar 18.

PMID:
24703295
28.

Tamoxifen induces resistance to activated protein C.

Rühl H, Schröder L, Müller J, Fimmers R, Sukhitashvili S, Welz J, Kuhn WC, Oldenburg J, Rudlowski C, Pötzsch B.

Thromb Res. 2014 May;133(5):886-91. doi: 10.1016/j.thromres.2014.02.004. Epub 2014 Feb 11.

PMID:
24568775
29.

Strong association of variants around FOXE1 and orofacial clefting.

Ludwig KU, Böhmer AC, Rubini M, Mossey PA, Herms S, Nowak S, Reutter H, Alblas MA, Lippke B, Barth S, Paredes-Zenteno M, Muñoz-Jimenez SG, Ortiz-Lopez R, Kreusch T, Hemprich A, Martini M, Braumann B, Jäger A, Pötzsch B, Molloy A, Peterlin B, Hoffmann P, Nöthen MM, Rojas-Martinez A, Knapp M, Steegers-Theunissen RP, Mangold E.

J Dent Res. 2014 Apr;93(4):376-81. doi: 10.1177/0022034514523987. Epub 2014 Feb 21.

PMID:
24563486
30.

Protamine-adsorbed magnetic nanoparticles for efficient isolation and concentration of hepatitis-C virus from human plasma samples.

Yassin AA, Elwaseef AM, Elnashar MM, Oldenburg J, Mayer G, Pötzsch B, Müller J.

Chem Commun (Camb). 2014 Jan 18;50(5):590-2. doi: 10.1039/c3cc46793g. Epub 2013 Nov 25.

PMID:
24275772
31.

Aptamer-guided caging for selective masking of protein domains.

Rohrbach F, Schäfer F, Fichte MA, Pfeiffer F, Müller J, Pötzsch B, Heckel A, Mayer G.

Angew Chem Int Ed Engl. 2013 Nov 4;52(45):11912-5. doi: 10.1002/anie.201306686. Epub 2013 Oct 14. No abstract available.

PMID:
24127310
32.

[Anticoagulation].

Pötzsch B.

Med Klin Intensivmed Notfmed. 2013 May;108(4):325-34; quiz 335-6. doi: 10.1007/s00063-013-0243-1. Review. German.

PMID:
23625324
33.

Resolution of giant left atrial appendage thrombus with rivaroxaban.

Hammerstingl C, Pötzsch B, Nickenig G.

Thromb Haemost. 2013 Apr;109(4):583-4. doi: 10.1160/TH12-11-0821. Epub 2013 Jan 24. No abstract available.

PMID:
23348106
34.

In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.

Pahl S, Pavlova A, Driesen J, Müller J, Pötzsch B, Oldenburg J.

Haemophilia. 2013 May;19(3):392-8. doi: 10.1111/hae.12076. Epub 2012 Dec 18.

PMID:
23252674
35.

Resequencing of VAX1 in patients with nonsyndromic cleft lip with or without cleft palate.

Nasser E, Mangold E, Tradowsky DC, Fier H, Becker J, Boehmer AC, Herberz R, Fricker N, Barth S, Wahle P, Nowak S, Reutter H, Reich RH, Lauster C, Braumann B, Kreusch T, Hemprich A, Pötzsch B, Hoffmann P, Kramer FJ, Knapp M, Lange C, Nöthen MM, Ludwig KU.

Birth Defects Res A Clin Mol Teratol. 2012 Nov;94(11):925-33. doi: 10.1002/bdra.23078. Epub 2012 Oct 18.

PMID:
23081944
36.

Chemical maturation of a bivalent aptamer by single domain variation.

Rohrbach F, Fatthalla MI, Kupper T, Pötzsch B, Müller J, Petersen M, Pedersen EB, Mayer G.

Chembiochem. 2012 Mar 19;13(5):631-4. doi: 10.1002/cbic.201200015. Epub 2012 Feb 13. No abstract available.

PMID:
22331608
37.

Thrombin inhibition profiles in healthy individuals and thrombophilic patients.

Rühl H, Müller J, Harbrecht U, Fimmers R, Oldenburg J, Mayer G, Pötzsch B.

Thromb Haemost. 2012 May;107(5):848-53. doi: 10.1160/TH11-10-0719. Epub 2012 Jan 25.

PMID:
22274722
38.

Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay.

Müller J, Friedrich M, Becher T, Braunstein J, Kupper T, Berdel P, Gravius S, Rohrbach F, Oldenburg J, Mayer G, Pötzsch B.

J Thromb Haemost. 2012 Mar;10(3):390-8. doi: 10.1111/j.1538-7836.2012.04623.x.

39.

Aptamer-based modulation of blood coagulation.

Mayer G, Rohrbach F, Pötzsch B, Müller J.

Hamostaseologie. 2011 Nov;31(4):258-63. doi: 10.5482/ha-1156. Review.

PMID:
22065102
40.

Profiling of active thrombin in human blood by supramolecular complexes.

Müller J, Becher T, Braunstein J, Berdel P, Gravius S, Rohrbach F, Oldenburg J, Mayer G, Pötzsch B.

Angew Chem Int Ed Engl. 2011 Jun 27;50(27):6075-8. doi: 10.1002/anie.201007032. Epub 2011 May 17. No abstract available.

PMID:
21591028
41.

Haemostasis management of massive bleeding.

Pötzsch B, Ivaskevicius V.

Hamostaseologie. 2011 Feb;31(1):15-20. doi: 10.5482/ha-1148. Review.

PMID:
21311819
42.

IRF6 gene variants in Central European patients with non-syndromic cleft lip with or without cleft palate.

Birnbaum S, Ludwig KU, Reutter H, Herms S, de Assis NA, Diaz-Lacava A, Barth S, Lauster C, Schmidt G, Scheer M, Saffar M, Martini M, Reich RH, Schiefke F, Hemprich A, Pötzsch S, Pötzsch B, Wienker TF, Hoffmann P, Knapp M, Kramer FJ, Nöthen MM, Mangold E.

Eur J Oral Sci. 2009 Dec;117(6):766-9. doi: 10.1111/j.1600-0722.2009.00680.x.

PMID:
20121942
43.

Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.

Buff MC, Schäfer F, Wulffen B, Müller J, Pötzsch B, Heckel A, Mayer G.

Nucleic Acids Res. 2010 Apr;38(6):2111-8. doi: 10.1093/nar/gkp1148. Epub 2009 Dec 8.

44.

Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-dependent coagulation factor activity in Western Germans.

Watzka M, Westhofen P, Hass M, Marinova M, Pötzsch B, Oldenburg J.

Thromb Haemost. 2009 Aug;102(2):418-20. doi: 10.1160/TH09-04-0217. No abstract available.

PMID:
19652895
45.

An exosite-specific ssDNA aptamer inhibits the anticoagulant functions of activated protein C and enhances inhibition by protein C inhibitor.

Müller J, Isermann B, Dücker C, Salehi M, Meyer M, Friedrich M, Madhusudhan T, Oldenburg J, Mayer G, Pötzsch B.

Chem Biol. 2009 Apr 24;16(4):442-51. doi: 10.1016/j.chembiol.2009.03.007.

46.

Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24.

Birnbaum S, Ludwig KU, Reutter H, Herms S, Steffens M, Rubini M, Baluardo C, Ferrian M, Almeida de Assis N, Alblas MA, Barth S, Freudenberg J, Lauster C, Schmidt G, Scheer M, Braumann B, Bergé SJ, Reich RH, Schiefke F, Hemprich A, Pötzsch S, Steegers-Theunissen RP, Pötzsch B, Moebus S, Horsthemke B, Kramer FJ, Wienker TF, Mossey PA, Propping P, Cichon S, Hoffmann P, Knapp M, Nöthen MM, Mangold E.

Nat Genet. 2009 Apr;41(4):473-7. doi: 10.1038/ng.333. Epub 2009 Mar 8.

PMID:
19270707
47.

Differential regulation of protein subdomain activity with caged bivalent ligands.

Mayer G, Müller J, Mack T, Freitag DF, Höver T, Pötzsch B, Heckel A.

Chembiochem. 2009 Mar 2;10(4):654-7. doi: 10.1002/cbic.200800814.

PMID:
19189364
48.

[Hemostasis and thrombosis research--an intensive course in clinical hemostasis].

Barthels M, Kemkes-Matthes B, Pötzsch B, Preissner KT, Riess H.

Hamostaseologie. 2008 Dec;28(5):255-6. German. No abstract available.

PMID:
19132157
49.

PCR-Based amplification of platelet mRNA sequences obtained from small-scale platelet samples.

Rox JM, Müller J, Pötzsch B.

Methods Mol Biol. 2009;496:285-92. doi: 10.1007/978-1-59745-553-4_18. Review.

PMID:
18839117
50.

Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.

Müller J, Freitag D, Mayer G, Pötzsch B.

J Thromb Haemost. 2008 Dec;6(12):2105-12. doi: 10.1111/j.1538-7836.2008.03162.x. Epub 2008 Sep 27.

Supplemental Content

Loading ...
Support Center